Last update 01 Nov 2024

Guangzhou Nuohao Pharmaceutical Technology Co Ltd

Private Company|
2007|
Guangdong Sheng, China

Overview

Tags

Nervous System Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
APP(Beta amyloid A4 protein)1

Related

1
Drugs associated with Guangzhou Nuohao Pharmaceutical Technology Co Ltd
L-clausenamide
Target
APP
Mechanism
APP inhibitors
Active Org.
Guangzhou Nuohao Pharmaceutical Technology Co Ltd [+4]
Originator Org.
Chinese Academy of Medical SciencesChinese Academy of Medical Sciences
Active Indication
Alzheimer Disease [+2]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Guangzhou Nuohao Pharmaceutical Technology Co Ltd
CTR20131933 / RecruitingPhase 2
左黄皮酰胺片治疗轻中度阿尔茨海默病的有效性和安全性的Ⅱa期临床探索研究
[Translation] Phase IIa clinical exploratory study on the efficacy and safety of levoclatamide tablets in the treatment of mild to moderate Alzheimer's disease
100 Clinical Results associated with Guangzhou Nuohao Pharmaceutical Technology Co Ltd
Login to view more data
0 Patents (Medical) associated with Guangzhou Nuohao Pharmaceutical Technology Co Ltd
Login to view more data
100 Deals associated with Guangzhou Nuohao Pharmaceutical Technology Co Ltd
Login to view more data
100 Translational Medicine associated with Guangzhou Nuohao Pharmaceutical Technology Co Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
L-clausenamide
 ( APP )		Alzheimer Disease
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free